Search
for
Sort by
Research 91–120 of 1000+
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Endocrine control of benign prostatic hyperplasia
- Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Hormonal manipulation of benign prostatic hyperplasia
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Prostate volume and its relationship with anthropometric variables among different ethnic groups of South-Kivu, DR Congo
- Steroid 5α-reductase inhibition by polymethoxyflavones